Back to search
Advanced Chronic Liver Disease, NASH
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Chronic Liver Disease, NASH trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Chronic Liver Disease, NASH trials you may qualify forLiver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation…
The investigators hypothesize that very low ketogenic diet could represent a new therapeutic option in the management of patients with MASLD and cACLD. Therefor…
Hypothesis: The severity of portal hypertension in compensated advanced chronic liver disease (cACLD) can be assessed using vibration controlled transient elast…
The prevalence of non-alcoholic fatty liver disease (NAFLD ) in the American population is approximately 30% in adults and 10% in children, making it the most c…
Serial combination of biological and elastography tests is accurate to diagnosing advanced fibrosis in non-alcoholic fatty liver disease (NAFLD) patients. In th…